Medical Hair Restoration
Below is a MRR and PLR article in category Health Fitness -> subcategory Hair Loss.
Medical Hair Restoration: Understanding Treatments and Options
Overview
Hair loss, affecting both men and women, is primarily caused by DHT (Dihydro-testosterone), a natural metabolite in our bodies. DHT prevents necessary proteins, vitamins, and minerals from nourishing hair follicles, shortening their growth phase (anagen) and extending their resting phase (telogen). This leads to hair thinning and loss.
Causes of Hair Loss
Unusual hair loss occurs due to changes in androgen metabolism involving the enzyme 5 alpha reductase. It combines with testosterone to form DHT, which accounts for 95% of hair loss. Some individuals are genetically predisposed to produce more DHT, contributing to hair loss patterns in both genders.
Treatment Approaches
DHT Blockers
Treatments focus on blocking DHT production to address male and female pattern hair loss (MPHL and FPHL). There are effective natural and pharmaceutical DHT blockers available for medical hair restoration.
Minoxidil
Minoxidil was the first drug approved for hair regrowth. The FDA approved a 2% solution for men in 1988 and later a 5% solution in 1997. For women, the 2% solution was approved in 1991. Although the 5% solution is not officially approved for women, many dermatologists use it successfully.
Mechanism: Minoxidil enhances potassium ion permeability, preventing calcium ions from entering cells, thereby promoting hair growth.
Precautions: It should be used cautiously in patients with cardiovascular conditions and is contraindicated for pregnant or nursing women.
Finasteride
Initially used to treat prostate enlargement (Proscar), finasteride was FDA-approved for MPHL in 1998 under the name Propecia.
Mechanism: It inhibits the enzyme 5α-reductase, reducing DHT levels, and stabilizing hair loss?"particularly effective in the crown area.
Usage: Many surgeons combine Propecia with surgical hair restoration for optimal results.
Combination Therapy
Reports suggest that using both finasteride and topical minoxidil can be more beneficial for mild to moderate MPHL, yielding better hair growth results.
Anti-Androgen Therapy
For women with elevated androgen levels who do not respond to minoxidil, anti-androgen treatments are available.
Options:
- UK: Cyproterone acetate (CPA) with ethinyl-estradiol.
- US: Spironolactone is a common alternative.
Flutamide
Flutamide has shown promise as a hair restoration treatment for women, especially those with hirsutism and hyperandrogenism, offering better results than CPA or finasteride for premenopausal women.
Conclusion
Hair loss restoration is a personalized and structured process. Understanding the different treatments and finding the right approach is crucial. For detailed information, consider consulting resources or professionals specializing in hair restoration.
You can find the original non-AI version of this article here: Medical Hair Restoration.
You can browse and read all the articles for free. If you want to use them and get PLR and MRR rights, you need to buy the pack. Learn more about this pack of over 100 000 MRR and PLR articles.